As a result of better management of rheumatoid arthritis, individuals with the condition are living longer. However, it is unknown if this represents different forms of the disease or a continuum of rheumatoid arthritis diagnosed at different stages.
Nonadherence to treatment regimens presents a barrier to optimal outcomes in RA and lupus.
Rapid expansion of effective therapies for psoriatic arthritis has driven new, ambitious treatment targets of minimal disease activity and disease remission.
Many variations of therapy for rheumatoid arthritis are now possible, and determining the optimal strategy for each patient is crucial to the success of treatment.
Fibromyalgia has remained a clinically nebulous entity, and one that is very difficult to manage effectively.
Thoracic manifestations are common in connective tissue disease, also called collagen vascular disease.
MRI allows to show changes to bone and cartilage, and to discriminate these from fluid and soft tissues around the joints, making it a good technique for measuring synovial volume and inflammation characteristic of RA.
Technological advances may assist children and adolescents with JIA, who are both more forgetful and more resistant to therapy.
The effect of rheumatic disease on vaccine safety in children was examined.
FENO monitoring may provide a biomarker of disease activity and signify the emergence of pulmonary involvement in kids with SLE.
